These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 35701841)
1. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. Zhang Y; Wang Y; Ji H; Ding J; Wang K J Exp Clin Cancer Res; 2022 Jun; 41(1):202. PubMed ID: 35701841 [TBL] [Abstract][Full Text] [Related]
2. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825 [TBL] [Abstract][Full Text] [Related]
3. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261 [TBL] [Abstract][Full Text] [Related]
5. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers. Lo Sardo F; Canu V; Maugeri-SaccĂ M; Strano S; Blandino G Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188756. PubMed ID: 35777600 [TBL] [Abstract][Full Text] [Related]
6. YAP and TAZ regulate skin wound healing. Lee MJ; Byun MR; Furutani-Seiki M; Hong JH; Jung HS J Invest Dermatol; 2014 Feb; 134(2):518-525. PubMed ID: 24108406 [TBL] [Abstract][Full Text] [Related]
7. Insights into recent findings and clinical application of YAP and TAZ in cancer. Franklin JM; Wu Z; Guan KL Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716 [TBL] [Abstract][Full Text] [Related]
8. Emerging roles of YAP/TAZ in lung physiology and diseases. Xie H; Wu L; Deng Z; Huo Y; Cheng Y Life Sci; 2018 Dec; 214():176-183. PubMed ID: 30385178 [TBL] [Abstract][Full Text] [Related]
9. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade. Budel SJ; Penning MM; Penning LC Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400 [TBL] [Abstract][Full Text] [Related]
10. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function. Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555 [TBL] [Abstract][Full Text] [Related]
11. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. Kim J; Kwon H; Shin YK; Song G; Lee T; Kim Y; Jeong W; Lee U; Zhang X; Nam G; Jeung HC; Kim W; Jho EH Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13529-13540. PubMed ID: 32482852 [TBL] [Abstract][Full Text] [Related]
12. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma. Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027 [TBL] [Abstract][Full Text] [Related]
13. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
14. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours. Rico C; Boerboom D; Paquet M Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264 [TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid negatively regulates YAP and TAZ expression in human cancer cells. Kim I; Lertpatipanpong P; Yoon Y; Lee J; Hong Y; Boonruang K; Ryu J; Baek SJ Biochim Biophys Acta Mol Cell Res; 2023 Dec; 1870(8):119556. PubMed ID: 37544381 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
17. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related]
18. The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ. Ester L; Cabrita I; Ventzke M; Kieckhöfer E; Christodoulou M; Mandel AM; Diefenhardt P; Fabretti F; Benzing T; Habbig S; Schermer B Hum Mol Genet; 2023 Nov; 32(22):3153-3165. PubMed ID: 37565816 [TBL] [Abstract][Full Text] [Related]
19. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities? Shreberk-Shaked M; Oren M Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214 [TBL] [Abstract][Full Text] [Related]
20. YAP and TAZ Take Center Stage in Cancer. Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]